Mark Neumann, EVP, Chief Commercial Officer: Intra-Cellular Therapies ITCI Sell · Filed 24/08/20

Trade details

Type: Insider sale
Amount: $1,405,047.12
Shares · price: 18,714 sh · $75.08 a share
Held after: 29,700 sh
Stock: Intra-Cellular Therapies ITCI
Person: Mark NeumannEVP, Chief Commercial Officer
Trade date: 24/08/16
Filed: 24/08/20
Days to filing: 4 days

Sold 38.7% of holdings

Share of holding sold: 38.7%

Intra-Cellular Therapies trades, last 26 weeks

What else happened in Intra-Cellular Therapies around then

Filed or reported within 30 days of the trade day · 24/07/17~24/09/15

Mark Neumann's recent trades

Mark NeumannEVP, Chief Commercial Officer
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$573.2K
8,636 sh
$573.2K
Filed 24/03/11
Traded 24/03/07
Mark NeumannEVP, Chief Commercial Officer
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$301K
4,496 sh
$301K
Filed 24/03/11
Traded 24/03/07
Mark NeumannEVP, Chief Commercial Officer
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$280.2K
4,303 sh
$280.2K
Filed 24/03/11
Traded 24/03/11
Mark NeumannEVP, Chief Commercial Officer
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$114K
1,729 sh
$114K
Filed 24/03/11
Traded 24/03/11
Mark NeumannEVP, Chief Commercial Officer
Sell10b5-1 planIntra-Cellular Therapies
Sell10b5-1 plan
Intra-Cellular Therapies
ITCI
$87.8K
1,313 sh
$87.8K
Filed 24/03/11
Traded 24/03/11